Answers are grounded in this paper and cite their sources.
The quest for a fully immunogenic vaccine against influenza H5N1 viruses has gone on for more than 10 years. Dr. Peter Wright writes that with tissue-culture–grown vaccine, the production schedule could be altered to permit incorporation of late-emerging threats.
No takes yet. Share an insight, caveat, or question.
Peter F. Wright (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: